Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Encephalitis, Japanese B”

72 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 72 results

Not applicableLooking for participantsNCT07358910
What this trial is testing

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Who this might be right for
DengueChikungunyaZika Virus Infection+55 more
Institut Pasteur du Cambodge 10,000
Post-approval studies (Phase 4)Study completedNCT01981967
What this trial is testing

Post-licensure Safety Study of IMOJEV® in Thailand

Who this might be right for
Japanese Encephalitis
Sanofi Pasteur, a Sanofi Company 10,000
Large-scale testing (Phase 3)Study completedNCT01246479
What this trial is testing

Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 23
Post-approval studies (Phase 4)UnknownNCT04817917
What this trial is testing

Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province

Who this might be right for
Japanese EncephalitisVaccine Preventable DiseaseVaccine Reaction
Zhejiang Provincial Center for Disease Control and Prevention 712
Not applicableStudy completedNCT02933710
What this trial is testing

Postmarketing Surveillance Study for IMOJEV® in Republic of Korea

Who this might be right for
Japanese Encephalitis
Sanofi Pasteur, a Sanofi Company 50
Not applicableStudy completedNCT01335412
What this trial is testing

Safety Surveillance After Immunization With IXIARO

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 20,000
Large-scale testing (Phase 3)Study completedNCT02492165
What this trial is testing

Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy Subjects

Who this might be right for
Japanese Encephalitis
Sanofi Pasteur, a Sanofi Company 250
Post-approval studies (Phase 4)Study completedNCT02880865
What this trial is testing

Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine

Who this might be right for
Encephalitis, JapaneseMeaslesMumps+1 more
PATH 628
Testing effectiveness (Phase 2)Study completedNCT06680128
What this trial is testing

Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults

Who this might be right for
Japanese Encephalitis Virus Disease
SK Bioscience Co., Ltd. 161
Large-scale testing (Phase 3)UnknownNCT04223037
What this trial is testing

Purified Inactivated Japanese Encephalitis Vaccine

Who this might be right for
Japanese Encephalitis Virus Disease
Chinese Academy of Medical Sciences 1,050
Post-approval studies (Phase 4)Study completedNCT01567865
What this trial is testing

Lot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine

Who this might be right for
Japanese Encephalitis
PATH 818
Large-scale testing (Phase 3)Study completedNCT00735644
What this trial is testing

Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines

Who this might be right for
Japanese EncephalitisHepatitis A
Sanofi Pasteur, a Sanofi Company 1,200
Large-scale testing (Phase 3)Study completedNCT01662440
What this trial is testing

Safety and Immunogenicity of 2 Different Vaccination Schedules of Rabies and Japanese Encephalitis Vaccines in Healthy Adult Subjects

Who this might be right for
RabiesJapanese Encephalitis
Novartis Vaccines 661
Post-approval studies (Phase 4)Study completedNCT01158599
What this trial is testing

This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 200
Testing effectiveness (Phase 2)UnknownNCT00216268
What this trial is testing

Treatment of Japanese Encephalitis

Who this might be right for
Japanese Encephalitis
Indian Council of Medical Research 200
Large-scale testing (Phase 3)Study completedNCT01900444
What this trial is testing

Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea

Who this might be right for
Japanese Encephalitis
Sanofi Pasteur, a Sanofi Company 119
Post-approval studies (Phase 4)Study completedNCT01815073
What this trial is testing

Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine

Who this might be right for
Japanese EncephalitisChickenpox
Changchun Keygen Biological Products Co., Ltd. 497
Not applicableStudy completedNCT00596102
What this trial is testing

Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 3,258
Testing effectiveness (Phase 2)Study completedNCT01943305
What this trial is testing

The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans

Who this might be right for
Yellow FeverEncephalitis, Japanese
Singapore General Hospital 84
Large-scale testing (Phase 3)Study completedNCT00596271
What this trial is testing

Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 192
Next Page